Drugs / Mometasone furoate/formoterol fumarate
last change Apr 2009 re-read 2 minutes ago

Mometasone furoate/formoterol fumarate

also known as MFF
Developed for
asthma
Investigated by
Novartis · Schering-Plough

Trials 1 · a red edge is where a trial was stopped

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00746330 Aug 2008 → Apr 2009 asthma Novartis Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Mometasone furoate/formoterol fumarate ClinicalTrials.gov intervention name — accepted as the source's own label NCT00746330
Known as MFF “Mometasone furoate/formoterol fumarate (MFF)” NCT00746330